RSS

therapeutics

Company focused on the discovery and optimisation of fully human antibodies, IONTAS, and a private biopharmaceutical company, aTen Therapeutics, have announced a collaboration for the discovery of therapeutic oncology leads. more

News

Horizon Discovery Group, gene editing and modulation technologies company, has entered into a non-exclusive out-licensing agreement with a US-based immune-oncology therapeutics developer. more

News

A review article, published in Frontiers in Medicine, states that collaboration between the pharma industry, patients and health regulators will be a ‘game changer’ in delivering cell and gene therapies to patients. more

News

Analyst company GBI Research has concluded that due to an increasing demand for type 2 diabetes mellitus (T2DM) therapeutics, there is a large and competitive market landscape. more

News

Bayer and Biontech, a immunotherapy company headquartered in Mainz have entered into an agreement to develop novel, first-in-class mRNA vaccines and therapeutics specifically for animal health applications. more

News

Researchers from Aalto University discuss how DNA molecules can be assembled into tailored and complex nanostructures, and further, how these structures can find uses in therapeutics and bionanotechnological applications more

News

A website has been launched by Avacta Life Sciences in order to showcase its new affimer technology. more

Technology

Comparing the antibodies of sharks, which are very old from an evolutionary perspective, with those of humans, a team of researchers at the Technische Universitaet Muenchen and the Helmholtz Zentrum Muenchen discovered stabilising mechanisms... more

News

SM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, has signed an agreement with Tunitas Therapeutics of San Francisco, US. The contract covers the initiation of process development activities by DSM for... more

Technology

Cambridge Research Biochemicals (CRB) has licensed the rights to a patentable method for parallel assembly of a large number of peptide-therapeutic cargo combinations. The company aims to launch a service in October to provide both researchers and... more

Technology